Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ELITE DIAGNOSTICS INC

NPI: 1861987083 · SAINT LOUIS, MO 63146 · Clinical Medical Laboratory · NPI assigned 06/29/2018

$3.23M
Total Medicaid Paid
33,866
Total Claims
20,981
Beneficiaries
5
Codes Billed
2020-11
First Month
2023-11
Last Month

Provider Details

Authorized OfficialNALLAMOTHU, NAVEEN (OWNER)
NPI Enumeration Date06/29/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 382 $7K
2021 563 $7K
2022 332 $26K
2023 32,589 $3.19M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 18,663 10,433 $1.82M
87913 13,891 9,540 $1.37M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 864 643 $39K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 413 332 $615.08
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count 35 33 $0.00